All In MedTech

Device Trial Radar · NCT04369833

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform Based on Artificial Intelligence Model Using Mathematical Analysis

Last checked: Nov 19, 2026Latest source record: May 9, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

130

Actual

Start

May 11, 2020

Primary completion

Sep 30, 2020

Study completion Sep 30, 2020

Sponsor

Lead sponsor
Pusan National University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 30, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to collect a variety of clinical data and blood glucose changes using a continuous glucose monitoring device for high-risk diabetes patients (prediabetes) in order to develop a personalized diabetes prevention and management platform based on artificial intelligence model using mathematical analysis.

Conditions

  • PreDiabetes
  • Glucose Metabolism Disorders
  • Diabetes Mellitus

Interventions

  • continuous glucose monitoring systemDevice

    wearing continuous glucose monitoring device (iPro2 professional continuous glucose monitoring, MedtronicⓇ, California, USA)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Insulin ResistanceTime frame: 1 week

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Pusan national university hospital

    Busan, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.